// file intentionally left blank ?>
Ensuring the best possible health for both a mother and her child begins before conception, pregnancy and at birth. Many diseases or conditions are preventable or their severity reduced when managed during the pre-pregnancy and pregnancy period, thus ensuring that a baby is born with the best health possible and maternal health is maintained. Our research in maternal child health through observational studies to randomized controlled trials is vital to answer many important questions regarding practices that will change care and improve maternal and child health.
From 2002-2009 OMNI’s ambition to create a maternal-infant cohort was inspired by the Framingham Heart Study. The Oak Birth Cohort has provided a rich source of data and biospecimens that can help us to direct future research endeavours for years to come. )
Our most recent significant endeavours include the Folic Acid Clinical Trial (FACT): an international, randomized, controlled trial to assess the efficacy of a new prevention strategy for managing women at high risk of developing preeclampsia. With the support and commitment from researchers around the world, our aim is find a definitive answer for the use of folic acid throughout pregnancy and its effects.
To find out more about FACT, please visit the FACT page